Earlier in Biotech
Moderna and Merck announced on June 5, 2024, that their investigational mRNA-based cancer vaccine, Intisemran (mRNA-4157/V940), significantly reduced the risk of melanoma recurrence and spread in patients with high-risk stage III/IV melanoma.
Human brain organoids, three-dimensional clusters of human cells that mimic the structure and function of the developing brain, have been successfully cultured in a laboratory for up to four years, according to research published online on August 19, 2026…
Gene editing technologies, particularly CRISPR-Cas9, have emerged as a revolutionary force in medicine, offering unprecedented potential to treat and cure genetic diseases. The ability to precisely alter DNA sequences holds promise for conditions previously considered untreatable, such as cystic fibrosis…
Moderna's messenger RNA (mRNA) influenza vaccine has received approval, marking a significant advancement in the fight against seasonal flu. This new vaccine technology offers the potential for manufacturers to respond more rapidly to the constantly changing strains of the influenza…
A significant scientific advancement has been achieved by researchers who have successfully employed a CRISPR-based technique to transform male mouse embryos into genetically female clones. This novel approach effectively removes the Y chromosome, resulting in female animals that are genetically…
Scientists have achieved a significant biological feat by creating female clones from male mouse embryos for the first time. A research team based in Japan employed a CRISPR-based method to remove the Y chromosome from male cells, thereby generating female…
Scientists in Japan have achieved a significant breakthrough by successfully transforming male mouse embryos into females for the first time, utilizing a CRISPR-based approach to remove the Y chromosome from male cells.
Researchers have developed a novel in vivo model capable of recovering human T cells directly from solid tumors, a breakthrough that allows for genome-wide CRISPR screens to identify specific targets for improving CAR T cell antitumour activity.
Researchers have identified a temporal uncoupling in the lineage progression of radial glial progenitor (RGP) cells within human cortical organoids, according to a study published online on August 12, 2026, in the journal Nature.
A study published online in Nature on August 12, 2026, has identified a significant immunological phenomenon linked to mRNA COVID-19 vaccination: a sustained IgG4 class switch. This switch, observed in individuals who received mRNA vaccines, is associated with an increased…
HuidaGene Therapeutics, a Shanghai-based biotechnology company, disclosed the death of a child approximately one year ago during a clinical trial for an investigational gene-editing therapy designed to treat Duchenne muscular dystrophy.
Chinese startup NeuroX has announced the development of a novel brain-computer interface (BCI) that claims to significantly reduce implantation time and invasiveness. The company states its BCI can be placed through a vein in as little as ten minutes…
The U.S. Food and Drug Administration (FDA) has granted approval for Moderna's trivalent flu vaccine, designated as mRNA-1010 and marketed under the name mFLUSIVA, for use in individuals aged 50 years and older.
The U.S. Food and Drug Administration (FDA) has granted approval for mFlusiva, a novel influenza vaccine developed by Moderna, marking the first use of mRNA technology in a flu shot for adults aged 50 and older.